Imigran (Sumatriptan)

Sumatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors located on intracranial blood vessels and trigeminal nerve fibers. This action causes constriction of dilated cranial vessels and blocks the release of inflammatory neuropeptides, thereby reducing pain transmission within the trigeminovascular pathway.

The prescribed dose of Imigran is determined by a qualified healthcare professional based on the individual’s clinical condition and response. Typically, a single 20 mg spray may be administered at the start of a migraine attack, with a possible second dose after two hours if needed, but exact dosing must follow the prescriber’s instructions.

The safety of Imigran during pregnancy or while breastfeeding has not been definitively established. Healthcare providers generally recommend avoiding sumatriptan unless the potential benefit justifies the potential risk to the fetus or infant. Pregnant or nursing patients should discuss alternative migraine management options with their physician.

To order Imigran, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Imigran belongs to the triptan class, which provides rapid relief by targeting serotonin receptors, unlike analgesics that only treat pain symptoms. Compared with oral triptans, the nasal spray offers faster absorption and may be preferable for patients with nausea or delayed gastric emptying. It is not a preventive therapy and is used only for acute attacks.

Imigran should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the nasal spray bottle tightly closed when not in use and out of reach of children. Do not refrigerate or freeze the product, as temperature extremes may affect spray performance.

Imigran is administered as a single nasal spray dose. The patient should tilt the head slightly forward, insert the nozzle into one nostril, and press the actuator to deliver the 20 mg dose. The spray may be repeated after at least two hours if the migraine persists, but no more than two doses should be taken within 24 hours unless directed by a physician.

Serious risks include coronary vasospasm leading to chest pain or myocardial ischemia, severe hypertension, and serotonin syndrome, especially when combined with other serotonergic drugs. Rare but life‑threatening allergic reactions such as anaphylaxis can also occur. Patients experiencing chest discomfort, severe headache, or signs of serotonin excess should seek immediate medical attention.

Imigran should be avoided in patients with a history of ischemic heart disease, uncontrolled hypertension, peripheral vascular disease, or severe hepatic impairment. It is also contraindicated in individuals who have experienced an allergic reaction to sumatriptan or any component of the nasal spray formulation. Pregnant or breastfeeding women should only use it if clearly prescribed by a physician.